Skip to main content
DI

Dimer Instruments

Dimer Instruments develops analytical instruments for real-time molecular analysis across the pharmaceutical development lifecycle. Their technology accelerates drug discovery and enhances product quality by providing high-resolution data on stability and binding kinetics. The platform supports applications from protein expression optimization to affinity screening with minimal sample consumption.

Santa Barbara, United StatesFounded 2023111K+ followers
Updated 4 months ago

Funding

$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Founders

Product

Problem

Pharmaceutical companies face challenges in monitoring critical quality attributes and process parameters during drug development and manufacturing. Traditional methods often lack real-time molecular analysis capabilities, hindering timely decision-making and potentially affecting product quality and consistency.

Solution

Dimer Instruments provides real-time molecular analysis instruments designed to monitor critical quality attributes and process parameters throughout the pharmaceutical development lifecycle. Their instruments enable biopharmaceutical companies to accelerate drug discovery, formulation, and manufacturing processes. By integrating real-time functionalities and innovative designs, Dimer Instruments delivers high-sensitivity, broad dynamic range, and rapid data acquisition, ensuring product quality and consistency while reducing the total cost of ownership through streamlined workflows and robust, low-maintenance designs. The product line includes instruments such as Prometheus, Monolith, Dianthus, and Andromeda, each tailored to address specific analytical challenges in protein stability, molecular interactions, affinity screening, and protein expression optimization.

Target Audience

The primary target audience includes pharmaceutical and biopharmaceutical companies involved in drug discovery, development, formulation, and manufacturing.

Features

  • **Prometheus Panta:** Measures conformational and colloidal stability of proteins in a single experiment.
  • **Monolith:** Measures the strength of molecular interactions in solution with minimal sample consumption, applicable to protein-protein interactions, small molecule affinities, and nucleic acid binding.
  • **Dianthus:** A plate-based affinity screening platform for identifying binding affinities in solution, suitable for fragment libraries and intrinsically disordered proteins.
  • **Andromeda X:** Uses high-sensitivity optics to optimize protein expression levels.
  • Real-time data acquisition for immediate insights into process parameters.
  • User-friendly software designed for both expert scientists and technicians.
  • Disposable self-indexing flow cells.
This profile is AI-generated and may contain inaccuracies.